Max Robotics — Global Service Robot Directory + US Certification

About

Steven MacLennan is a leading urological researcher whose work has fundamentally shaped evidence-based surgical practice, particularly through high-impact systematic reviews and guideline implementation. His primary research areas encompass surgical outcomes for renal cancer, upper tract urothelial carcinoma, and the standardization of complication reporting in urologic oncology. MacLennan’s most influential contribution is his landmark 2012 systematic review on perioperative and quality-of-life outcomes following surgical management of localized renal cancer, which has garnered 288 citations and serves as a cornerstone for clinical decision-making. He further advanced the field with a pivotal European Association of Urology (EAU) guidelines systematic review comparing laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma (156 citations), providing crucial oncological outcome data. Notably, his 2018 study on implementing EAU guidelines for reporting and grading complications demonstrated how standardized protocols can improve perioperative outcomes after robot-assisted radical prostatectomy (72 citations). Through his rigorous methodological approach and direct engagement with guideline development, MacLennan has bridged the gap between research evidence and clinical practice, making him an essential figure for students and researchers interested in evidence-based urologic surgery and outcomes research.